- Volpara Health Technologies (VHT) has signed a contract with BreastScreen Queensland, Australia’s third-largest public breast screening program
- The five-year contract will see Volpara roll out its software platform, VolparaEnterprise, to 11 BreastScreen Queensland services
- Volpara Enterprise delivers high-quality breast imaging services as well as key performance indicators through an interactive dashboard
- The platform has begun rolling out and the company expects it will officially go live early next year
- Terms and conditions of the contract remain confidential
- VHT is up 4.15 percent and shares are trading at $1.38